Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Therapy Name||Capecitabine + CPI-100|
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|CPI-100||CPI-100 is a preparation of nanoparticles containing an undisclosed payload, which may stimulate immune response or inhibit tumor growth (NCI Drug Dictionary).|
|Capecitabine||Xeloda||R340||Chemotherapy - Antimetabolite 13||Xeloda (capecitabine) is an antimetabolite that when activated to 5-FU ultimately inhibits DNA synthesis and cell division (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT03781362||Phase I||CPI-100 Capecitabine + CPI-100||Study of CPI-100 in Patients With Advanced Tumors||Recruiting||USA||0|